Terms: = Prostate cancer AND PDGFB, SIS, 5155, ENSG00000100311, FLJ12858, PDGF2, P01127, c-sis, SSV AND Diagnosis
10 results:
1. pdgfb-targeted functional MRI nanoswitch for activatable T
Zhang Y; Liu L; Li W; Zhang C; Song T; Wang P; Sun D; Huang X; Qin X; Ran L; Tian G; Qian J; Zhang G
J Nanobiotechnology; 2023 Jan; 21(1):9. PubMed ID: 36609374
[TBL] [Abstract] [Full Text] [Related]
2. Race-specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990-2017.
Oehrlein N; Streicher SA; Kuo HC; Chaurasia A; McFadden J; Nousome D; Chen Y; Stroup SP; Musser J; Brand T; Porter C; Rosner IL; Chesnut GT; Onofaro KC; Rebbeck TR; D'Amico A; Lu-Yao G; Cullen J
Cancer Med; 2022 Nov; 11(22):4354-4365. PubMed ID: 35638719
[TBL] [Abstract] [Full Text] [Related]
3. Robotic-assisted radical prostatectomy in young adults: age-stratified oncological and functional outcomes.
Bhat KRS; Onol FF; Moschovas MC; Reddy S; Noel J; Rogers T; Coelho R; Rocco B; Patel V
J Robot Surg; 2022 Oct; 16(5):1057-1066. PubMed ID: 34813023
[TBL] [Abstract] [Full Text] [Related]
4. Combining PHI and miRNAs as Biomarkers in prostate cancer Diagnosis and Prognosis.
Ibrahim NH; Abdellateif MS; Thabet G; Kassem SH; El-Salam MA; El-Leithy AA; Selim MM
Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307177
[TBL] [Abstract] [Full Text] [Related]
5. [Stigmatization in Employed Patients with Breast, Intestinal, prostate and Lung cancer].
Ernst J; Mehnert A; Taubenheim S; Rentsch A; Hornemann B; Esser P
Psychother Psychosom Med Psychol; 2017 Jul; 67(7):304-311. PubMed ID: 28719922
[No Abstract] [Full Text] [Related]
6. Metastatic prostate cancer in the modern era of PSA screening.
Fontenot PA; Nehra A; Parker W; Wyre H; Mirza M; Duchene DA; Holzbeierlein J; Thrasher JB; Van Veldhuizen P; Lee EK
Int Braz J Urol; 2017; 43(3):416-421. PubMed ID: 28338310
[TBL] [Abstract] [Full Text] [Related]
7. Screening for prostate cancer Starting at Age 50-54 Years. A Population-based Cohort Study.
Carlsson S; Assel M; Ulmert D; Gerdtsson A; Hugosson J; Vickers A; Lilja H
Eur Urol; 2017 Jan; 71(1):46-52. PubMed ID: 27084245
[TBL] [Abstract] [Full Text] [Related]
8. Inflammatory prostate cancer: an underestimated paraneoplastic clinical manifestation.
Mauri D; Pentheroudakis G; Tolis C; Chojnacka M; Pavlidis N
Urol Oncol; 2005; 23(5):318-22. PubMed ID: 16144664
[TBL] [Abstract] [Full Text] [Related]
9. [Intervention of the family physician in the diagnosis of cancer].
Simó Cruzet E; Ureña Tapia MM; Vernet Vernet M; Sender Palacios MJ; Larrossa Sáez P; Jovell Fernández E
Aten Primaria; 2000 Jun; 26(2):104-6. PubMed ID: 10927827
[TBL] [Abstract] [Full Text] [Related]
10. Oncogene-related serum proteins and cancer risk: a nested case-control study.
Weissfeld JL; Larsen RD; Niman HL; Kuller LH
Am J Epidemiol; 1996 Oct; 144(8):723-7. PubMed ID: 8857820
[TBL] [Abstract] [Full Text] [Related]
